Posted On: 02/25/2016 3:13:57 PM
Post# of 72446
New study: pancreatic cancer has 4 sub-types, best treatment depends on which type it is.
https://www.yahoo.com/finance/news/pancreatic...08775.html
This is really important for the CTIX pancreatic trial that's being planned. If they can classify which type the patients have, it's possible that it will work on one type but not another -- so instead of a trial not helping most so being classified as a failure, even if Kevetrin only helps one or two types, because it would be known that it works on a certain type, it would be a positive result.
This of course assumes that it DOES work on one of more types, which we won't know until the trial is concluded.
https://www.yahoo.com/finance/news/pancreatic...08775.html
This is really important for the CTIX pancreatic trial that's being planned. If they can classify which type the patients have, it's possible that it will work on one type but not another -- so instead of a trial not helping most so being classified as a failure, even if Kevetrin only helps one or two types, because it would be known that it works on a certain type, it would be a positive result.
This of course assumes that it DOES work on one of more types, which we won't know until the trial is concluded.
(0)
(0)
